SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-046226
Filing Date
2007-03-05
Accepted
2007-03-05 14:04:11
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 842676
2 LIST OF SUBSIDIARIES dex21.htm EX-21 2925
3 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP dex231.htm EX-23.1 2306
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) dex311.htm EX-31.1 9288
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) dex312.htm EX-31.2 9565
6 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. 1350 dex32.htm EX-32 4733
  Complete submission text file 0001193125-07-046226.txt   872956
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 07670640
SIC: 2836 Biological Products, (No Diagnostic Substances)